title: Epilepsy is ubiquitous, but more devastating in the poorer regions of the world... or is it?
abstract: The incidence and prevalence of active epilepsy are greatest in Africa compared to all other continents, even those with equivalent poor settings. This is a reflection of the high levels of structural and metabolic causes and may reflect an increased risk in parts of the continent. The full burden of epilepsy, which includes the social and medical morbidity of the disorder and where people with epilepsy are heavily stigmatized and frequently untreated, cannot be fully assessed even using the disability adjusted life-years, since the assigned disability weights are not specific to these regions. The burden is further exacerbated by social, geographic, and economic barriers to care and the inability of African health systems to manage people with epilepsy effectively because of lack of trained personnel, limited facilities, and poor access to effective or sustained supplies of antiepileptic drugs, or even therapy at all. The situation is compounded by a probable underestimation of the prevalence and incidence of people with epilepsy related to the major stigma associated with the condition in Africa, and the limited training available to most health care workers who are the primary point of assessing most people with epilepsy. Finding innovative ways to address the huge barriers faced by people with epilepsy in Africa needs to be a major goal for the millennium. A PowerPoint slide summarizing this article is available for download in the Supporting Information section here.
authors.affiliation: Department of Pediatric Neurology, Red Cross War Memorial Children's Hospital, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.
authors.forename: Jo M
authors.initials: JM
authors.lastname: Wilmshurst
authors.forename: Gretchen L
authors.initials: GL
authors.lastname: Birbeck
authors.forename: Charles R
authors.initials: CR
authors.lastname: Newton
mesh_terms: D000927:Anticonvulsants; D003695:Delivery of Health Care; D004827:Epilepsy / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology* / Q000523:psychology; D014943:Global Health; D006801:Humans; D015994:Incidence; D010616:Phenanthrenes
chemical_list: D000927:Anticonvulsants; D010616:Phenanthrenes; C414695:stigmalactam
keywords: Africa; Epidemiology; Epilepsy; Incidence; Prevalence
references.citation: Lancet Neurol. 2012 Aug;11(8):688-96
references.pmid: 22770914
references.citation: Epilepsia. 2010 May;51(5):883-90
references.pmid: 20067507
references.citation: Neurology. 2014 Feb 18;82(7):582-9
references.pmid: 24443454
references.citation: Epilepsia. 2013 Mar;54(3):512-7
references.pmid: 23215769
references.citation: Epilepsy Res. 2005 Aug-Sep;66(1-3):63-74
references.pmid: 16125900
references.citation: Lancet Neurol. 2013 Mar;12(3):253-63
references.pmid: 23375964
references.citation: Epilepsia. 2012 Dec;53(12):2178-85
references.pmid: 23106784
references.citation: Lancet Neurol. 2007 Jan;6(1):39-44
references.pmid: 17166800
references.citation: Cochrane Database Syst Rev. 2013 Jan 31;(1):CD002217
references.pmid: 23440786
references.citation: Epilepsy Behav. 2007 May;10(3):456-62
references.pmid: 17363333
references.citation: PLoS Med. 2009 Oct;6(10):e1000162
references.pmid: 19823570
references.citation: Bull World Health Organ. 2010 Apr;88(4):260-6
references.pmid: 20431789
references.citation: Lancet. 1998 Jan 3;351(9095):19-23
references.pmid: 9433424
references.citation: Handb Clin Neurol. 2013;111:707-18
references.pmid: 23622218
references.citation: Lancet Neurol. 2007 Jun;6(6):533-43
references.pmid: 17509488
references.citation: Epilepsy Behav. 2012 Dec;25(4):614-21
references.pmid: 23160097
references.citation: Epilepsy Behav. 2006 Sep;9(2):275-80
references.pmid: 16877045
references.citation: Epilepsia. 2008 Sep;49(9):1491-503
references.pmid: 18557778
references.citation: Epilepsy Behav. 2005 Aug;7(1):68-73
references.pmid: 15978874
references.citation: Am J Trop Med Hyg. 2008 Aug;79(2):168-72
references.pmid: 18689619
references.citation: Epilepsia. 2005;46 Suppl 11:33-5
references.pmid: 16393176
references.citation: Lancet. 2012 Dec 15;380(9859):2197-223
references.pmid: 23245608
references.citation: Lancet Neurol. 2005 Jan;4(1):21-31
references.pmid: 15620854
references.citation: Neurology. 2011 Sep 6;77(10):1005-12
references.pmid: 21893672
references.citation: BMJ. 2007 Jun 9;334(7605):1207
references.pmid: 17145735
references.citation: Lancet. 2012 Sep 29;380(9848):1193-201
references.pmid: 23021288